Gastroenterology

Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.

Gastroenterology

Sandborn WJ, Korzenik J, Lashner B, Leighton JA, Mahadevan U, Marion JF, Safdi M, Sninsky CA, Patel RM, Friedenberg KA, Dunnmon P, Ramsey D, Kane S

A cost-utility analysis of ablative therapy for Barrett's esophagus.

Gastroenterology

Inadomi JM, Somsouk M, Madanick RD, Thomas JP, Shaheen NJ

Infliximab and surgical complications: truth or perception?

Gastroenterology

Sewell JL, Mahadevan U

Pages